Position in ROIV
as of Mar 31, 2026
· filed Apr 17, 2026
Position Value
$40,746
+$9,368 QoQ
Shares Held
1,471
+1.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
15 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bell Investment Advisors, Inc holds $351,465 across 64 Biotechnology names. ROIV ranks #2 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
129 | $57,603 | |
| 2 | ROIV |
Roivant Sciences Ltd.
This page
|
1,471 | $40,746 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
44 | $33,996 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
53 | $17,536 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
223 | $16,559 | |
| 6 | INCY |
Incyte Corp
|
156 | $14,682 | |
| 7 | ARGX |
Argenx SE
|
18 | $13,144 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
177 | $11,439 |
All Filings in ROIV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $40,746 | 1,471 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $31,378 | 1,446 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $16,204 | 1,071 | Shares | Sole | 2025-11-21 | |
| 2025-06-30 | $13,738 | 1,219 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $8,203 | 813 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $10,788 | 912 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $8,620 | 747 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,299 | 596 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $6,281 | 596 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $6,693 | 596 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,258 | 279 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,961 | 393 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,900 | 393 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $3,140 | 393 | Shares | Sole | 2023-02-09 | |
| 2021-12-31 | $483 | 48 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||